Abstract
The objective of this study is to build up a kind of effective approach to multiply CD133+ endothelial progenitor cells (EPCs) and visualize cells by labeling with two FDA-approved agents based on MRI technique. CD133+ cells were separated by immunomagnetic microbeads selection and grew with serum-free medium. Seven days later, CD133+ cell production was collected and co-incubated with iron complex for 24 h for labeling. The iron-labeled cells were suspended into agarose gel and scanned by MRI for visualization. Labeled cells were also analyzed for cell viability. Iron can be effectively introduced into CD133+ EPCs plasma in culture and visualized by changing the MRI signal intensity. Iron had no influence on cell viability. Conclusion: Iron substance can be applied to label CD133+ cells without cytotoxicity and iron-labeled cells can be visualized by MRI image. Due to the non-invasive property and repeatability of MRI technology and this kind of method could be used for tracing in vivo stem cells in the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Khakoo AY, Finkel T (2005) Endothelial progenitor cells. Annu Rev Med 56:79–101
Lapergue B, Mohammad A, Shuaib A (2007) Endothelial progenitor cells and cerebrovascular diseases. Prog Neurobiol 83:349–362
Boodhwani M, Sodha NR, Mieno S et al (2007) Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation 116(11 Suppl):I31–37
Asahara T, Kawamoto A (2004) Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287:C572–579
Si Z, Liu J (2008) What “helps” tumors evade vascular targeting treatment? Chin Med J 121:844–849
Lyden D, Hattori K, Dias S et al (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194–1201
Shaked Y, Ciarrocchi A, Franco M et al (2006) Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313:1785–1787
Cho HJ, Lee N, Lee JY et al (2007) Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 204:3257–3269
Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266–1276
Matuszewski L, Persigehl T, Wall A et al (2006) Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 235:155–161
Frank JA, Miller BR, Arbab AS et al (2003) Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228:480–487
Mai XL, Teng GJ, Ma ZL et al (2007) In vitro MR imaging of Fe(2)O(3)-PLL labelled rabbit peripheral blood endothelial progenitor cells. Chin J Cardiol 35:838–843
Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702–712
Author information
Authors and Affiliations
Corresponding author
Additional information
Jie Liu and Baoting Chao contributed equally to this work.
Rights and permissions
About this article
Cite this article
Liu, J., Chao, B. MRI-based Visualization of Iron-labeled CD133+ Human Endothelial Progenitor Cells. Biol Trace Elem Res 126, 83–91 (2008). https://doi.org/10.1007/s12011-008-8192-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-008-8192-x